ArticlesPricing

Products

See All Solutions →
By ProductEMARKETER PRO+Analyst Access Program
By Use CaseDetermine Market SizingDevelop StrategiesAllocate BudgetBenchmark PerformanceWin New BusinessDevelop Go-to-Market StrategyStay InformedThought LeadershipSee All Use Cases →
Advertising & Sponsorship
Boost your brand and generate demand with media programs.
Learn More →

Events & Resources

Learning Center
Read through guides, explore resource hubs, and sample our coverage.
Learn More →
Events
Register for an upcoming webinar and track which industry events our analysts attend.
Learn More →
Podcasts
Listen to our podcast, Behind the Numbers for the latest news and insights.
Learn More →

Topics

See All Topics →
Advertising & MarketingSocial MediaContent MarketingEmail MarketingVideoBrowse All →
Ecommerce & RetailEcommerce SalesMcommerceRetail SalesSocial CommerceBrowse All →
Financial ServicesBankingPaymentsFintechWealth ManagementBrowse All →
GeographiesAsia-PacificCentral & Eastern EuropeLatin AmericaMiddle East & AfricaNorth AmericaWestern Europe
HealthValue-Based CareDigital TherapeuticsTelehealthOnline PharmacyBrowse All →
TechnologyConnected Devices5GArtificial Intelligence (AI)Browse All →
More IndustriesReal EstateCustomer ExperienceB2BTravelSmall Business (SMB)Browse All →

Latest Articles

Explore our Research →

The big answers: EMARKETER Daily quiz

Article |
 Aug 1, 2025

Revolut could soon become a full-service US bank

Article |
 Aug 1, 2025

Nano-influencers earn impressive impression, engagement rates

Article |
 Aug 1, 2025

JPMorgan-Coinbase partnership could change customers’ relationship with crypto

Article |
 Aug 1, 2025

Trump intensifies threats against pharma if drugmakers don’t lower US prices

Article |
 Aug 1, 2025

AI streamlines health report filings in Merck, McKinsey collab

Article |
 Aug 1, 2025

United tries time-sensitive travel promotions to boost cardholder bookings

Article |
 Aug 1, 2025

Klarna mulls possible September IPO

Article |
 Aug 1, 2025

Competitive conquesting gains ground among RMNs

Article |
 Jul 31, 2025

Parents prioritize value, convenience during back-to-school shopping

Article |
 Jul 31, 2025
Browse All →

About

Our Story
Learn more about our mission and how EMARKETER came to be.
Learn More →
Our Clients
Key decision-makers share why they find EMARKETER so critical.
Learn More →
Our People
Take a look into our corporate culture and view our open roles.
Join the Team →
Our Methodology
Rigorous proprietary data vetting strips biases and produces superior insights.
Learn More →
Newsroom
See our latest press releases, news articles or download our press kit.
Learn More →
Contact Us
Speak to a member of our team to learn more about EMARKETER.
Contact Us →
EMARKETER

Novo Nordisk partners with Hims & Hers, Ro, LifeMD to offer discounted Wegovy

Article by Rajiv Leventhal  |  Apr 29, 2025
Download
Novo Nordisk partners with Hims & Hers, Ro, LifeMD to offer discounted Wegovy
Share
Topics
Digital Health
United States

The news: Novo Nordisk will offer its weight loss drug Wegovy at a discounted price for cash-paying patients via three telehealth providers.

Consumers eligible for a Wegovy prescription can get it at Hims & Hers, Ro, and LifeMD for $499 per month (or $599 at Hims since other medical services are included). That’s over half off the drug’s monthly list price. The three telehealth companies will integrate with Novo’s new D2C online pharmacy, NovoCare, to complete medication orders.

Zooming in: Novo’s tie-up with Hims is the most surprising piece of this news considering their public feud over Hims selling compounded semaglutide (Wegovy).

You've read 0 of 2 free articles this month.

Create an account for uninterrupted access to select articles.
Create a Free Account